Research graph
References from Chemokines and chemokine receptors during COVID-19 infection. Local targets link to admitted publications; unresolved targets remain external evidence.
Temporal profiling of plasma cytokines, chemokines and growth factors from mild, severe and fatal COVID-19 patients
10.1038/s41392-020-0211-1 · 2020 · External reference
A novel coronavirus from patients with pneumonia in China, 2019
10.1056/nejmoa2001017 · 2020 · External reference
10.1016/s0140-6736(20)30183-5
10.1016/s0140-6736(20)30183-5 · External reference
10.1172/jci137244
10.1172/jci137244 · External reference
10.1093/nsr/nwaa041
10.1093/nsr/nwaa041 · External reference
Immune response, inflammation, and the clinical spectrum of COVID-19
10.3389/fimmu.2020.01441 · 2020 · External reference
10.1038/s41423-020-0402-2
10.1038/s41423-020-0402-2 · External reference
10.1016/j.clim.2020.108448
10.1016/j.clim.2020.108448 · External reference
10.1038/s41577-020-0311-8
10.1038/s41577-020-0311-8 · External reference
10.1126/science.abb8925
10.1126/science.abb8925 · External reference
10.1189/jlb.1102577
10.1189/jlb.1102577 · External reference
10.1038/nri980
10.1038/nri980 · External reference
10.4049/jimmunol.164.8.4048
10.4049/jimmunol.164.8.4048 · External reference
Expression and regulation of chemokine receptors in human natural killer cells
10.1182/blood.v97.2.367 · 2001 · External reference
C-C chemokines induce the chemotaxis of NK and IL-2-activated NK cells. Role for G proteins
10.4049/jimmunol.153.11.4969 · 1994 · External reference
Interferon-inducible protein-10 and lymphotactin induce the chemotaxis and mobilization of intracellular calcium in natural killer cells through pertussis toxin-sensitive and -insensitive heterotrimeric G-proteins
10.1096/fasebj.11.10.9271361 · 1997 · External reference
10.1016/s0966-842x(03)00157-4
10.1016/s0966-842x(03)00157-4 · External reference
10.1002/eji.1830260207
10.1002/eji.1830260207 · External reference
10.1084/jem.20021522
10.1084/jem.20021522 · External reference
10.1084/jem.187.1.1
10.1084/jem.187.1.1 · External reference
10.1097/00130832-200312000-00008
10.1097/00130832-200312000-00008 · External reference
10.1016/j.virol.2005.09.024
10.1016/j.virol.2005.09.024 · External reference
Serum IFN-γ-induced protein 10 (IP-10) as a biomarker for severity of acute respiratory infection in healthy adults
10.1016/j.jcv.2017.03.003 · 2017 · External reference
Host response cytokine signatures in viral and nonviral acute exacerbations of chronic obstructive pulmonary disease
10.1089/jir.2010.0131 · 2011 · External reference
Serum IP-10 as a biomarker of human rhinovirus infection at exacerbation of COPD
10.1378/chest.09-1541 · 2010 · External reference
Association of interleukin-8 and neutrophils with nasal symptom severity during acute respiratory infection
10.1002/jmv.24042 · 2015 · External reference
10.1002/eji.1830271004
10.1002/eji.1830271004 · External reference
Intrahepatic IP-10 mRNA and plasma IP-10 levels as response marker for HBeAg-positive chronic hepatitis B patients treated with peginterferon and adefovir
10.1016/j.antiviral.2016.05.002 · 2016 · External reference
Plasma IP-10 is associated with rapid disease progression in early HIV-1 infection
10.1089/vim.2012.0011 · 2012 · External reference
High IP-10 levels decrease T cell function in HIV-1-infected individuals on ART
10.1189/jlb.3a0414-232rr · 2014 · External reference
10.1016/s0002-9440(10)65068-7
10.1016/s0002-9440(10)65068-7 · External reference
10.1128/jvi.75.2.878-890.2001
10.1128/jvi.75.2.878-890.2001 · External reference
Increased expression of T cell chemokines and their receptors in chronic hepatitis C: relationship with the histological activity of liver disease
10.1111/j.1572-0241.2002.07054.x · 2002 · External reference
10.1172/jci9232
10.1172/jci9232 · External reference
10.1126/science.7667639
10.1126/science.7667639 · External reference
Expression of macrophage inflammatory protein (MIP)-1α, MIP-1β, and RANTES genes in lymph nodes from HIV+ individuals: correlation with a Th1-type cytokine response
10.1046/j.1365-2249.1998.00555.x · 1998 · External reference
10.1126/science.270.5243.1811
10.1126/science.270.5243.1811 · External reference
10.1126/science.272.5270.1955
10.1126/science.272.5270.1955 · External reference
Chemokine receptor-specific antibodies in cancer immunotherapy: achievements and challenges
10.3389/fimmu.2015.00012 · 2015 · External reference
The expanding therapeutic perspective of CCR5 blockade
10.3389/fimmu.2017.01981 · 2018 · External reference
10.1007/s40495-015-0044-8
10.1007/s40495-015-0044-8 · External reference
10.1038/382722a0
10.1038/382722a0 · External reference
10.1016/j.ejmech.2016.02.051
10.1016/j.ejmech.2016.02.051 · External reference
10.1080/13543784.2016.1254615
10.1080/13543784.2016.1254615 · External reference
10.1021/jm900492g
10.1021/jm900492g · External reference
Endogenous CCL2 neutralization restricts HIV-1 replication in primary human macrophages by inhibiting viral NA accumulation
10.1186/s12977-014-0132-6 · 2015 · External reference
Chemokines and chemokine receptors: accomplices for human immunodeficiency virus infection and latency
10.3389/fimmu.2017.01274 · 2017 · External reference
MERS-CoV infection is associated with downregulation of genes encoding Th1 and Th2 cytokines/chemokines and elevated inflammatory innate immune response in the lower respiratory tract
10.1016/j.cyto.2019.154895 · 2020 · External reference
Uncontrolled innate and impaired adaptive immune responses in patients with COVID-19 ARDS
10.1164/rccm.202005-1885oc · 2020 · External reference
Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome
10.1001/jama.290.3.374 · 2003 · External reference
A human in vitro model system for investigating genome-wide host responses to SARS coronavirus infection
10.1186/1471-2334-4-34 · 2004 · External reference
10.1016/j.coi.2005.05.009
10.1016/j.coi.2005.05.009 · External reference
10.1128/jvi.01281-09
10.1128/jvi.01281-09 · External reference
10.1128/jvi.00527-07
10.1128/jvi.00527-07 · External reference
10.4049/jimmunol.173.6.4030
10.4049/jimmunol.173.6.4030 · External reference
10.1099/jgv.0.000351
10.1099/jgv.0.000351 · External reference
10.1111/j.1365-2249.2004.02415.x
10.1111/j.1365-2249.2004.02415.x · External reference
10.1093/infdis/jit504
10.1093/infdis/jit504 · External reference
Comparative analysis of the human macrophage inflammatory protein family of cytokines (chemokines) on proliferation of human myeloid progenitor cells. Interacting effects involving suppression, synergistic suppression, and blocking of suppression
10.4049/jimmunol.150.8.3448 · 1993 · External reference
10.1038/nm1143
10.1038/nm1143 · External reference
10.1128/jvi.79.12.7819-7826.2005
10.1128/jvi.79.12.7819-7826.2005 · External reference
Infection of cultured intestinal epithelial cells with severe acute respiratory syndrome coronavirus
10.1007/s00018-004-4222-9 · 2004 · External reference
Inhibition of cytokine gene expression and induction of chemokine genes in non-lymphatic cells infected with SARS coronavirus
10.1186/1743-422x-3-17 · 2006 · External reference
10.1182/blood-2004-10-4166
10.1182/blood-2004-10-4166 · External reference
Modeling the early events of severe acute respiratory syndrome coronavirus infection in vitro
10.1128/jvi.80.6.2684-2693.2006 · 2006 · External reference
10.1128/mcb.19.2.959
10.1128/mcb.19.2.959 · External reference
10.1074/jbc.m101216200
10.1074/jbc.m101216200 · External reference
10.1016/j.cell.2004.08.007
10.1016/j.cell.2004.08.007 · External reference
10.1016/j.cytogfr.2020.05.003
10.1016/j.cytogfr.2020.05.003 · External reference
10.4049/jimmunol.162.8.4928
10.4049/jimmunol.162.8.4928 · External reference
10.1016/j.cytogfr.2008.01.001
10.1016/j.cytogfr.2008.01.001 · External reference
10.1016/j.chom.2016.01.007
10.1016/j.chom.2016.01.007 · External reference
10.1016/s0046-8177(03)00367-8
10.1016/s0046-8177(03)00367-8 · External reference
10.1016/s0140-6736(03)13413-7
10.1016/s0140-6736(03)13413-7 · External reference
10.1038/nri3070
10.1038/nri3070 · External reference
Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome
10.1164/ajrccm.154.3.8810593 · 1996 · External reference
Phenotypic characterization of alveolar monocyte recruitment in acute respiratory distress syndrome
10.1152/ajplung.2000.279.1.l25 · 2000 · External reference
A cluster of cases of severe acute respiratory syndrome in Hong Kong
10.1056/nejmoa030666 · 2003 · External reference
Critical role for the chemokine MCP-1/CCR2 in the pathogenesis of bronchiolitis obliterans syndrome
10.1172/jci200112214 · 2001 · External reference
10.4049/jimmunol.167.8.4635
10.4049/jimmunol.167.8.4635 · External reference
10.1016/j.virusres.2004.09.004
10.1016/j.virusres.2004.09.004 · External reference
10.1128/jvi.79.21.13800-13805.2005
10.1128/jvi.79.21.13800-13805.2005 · External reference
10.1007/s00281-017-0629-x
10.1007/s00281-017-0629-x · External reference
Interactions between neutrophils and cytokines in blood and alveolar spaces during ARDS
10.1164/ajrccm.154.3.8810592 · 1996 · External reference
10.1164/rccm.200407-857oc
10.1164/rccm.200407-857oc · External reference
GRO alpha and interleukin-8 in Pneumocystis carinii or bacterial pneumonia and adult respiratory distress syndrome
10.1164/ajrccm.152.5.7582292 · 1995 · External reference
10.1164/ajrccm.150.1.8025736
10.1164/ajrccm.150.1.8025736 · External reference
Lung neutrophils in the adult respiratory distress syndrome. Clinical and pathophysiologic significance
1986 · External reference
The role of neutrophil elastase in acute lung injury
10.1016/s0014-2999(02)02182-9 · 2002 · External reference
10.1093/infdis/jiv380
10.1093/infdis/jiv380 · External reference
10.1371/journal.ppat.1000240
10.1371/journal.ppat.1000240 · External reference
Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: lessons from SARS and MERS, and potential therapeutic interventions
10.1016/j.lfs.2020.118102 · 2020 · External reference
10.4049/jimmunol.180.4.2641
10.4049/jimmunol.180.4.2641 · External reference
Chemokine-receptor upregulation and disease severity in respiratory syncytial virus infection
10.1016/j.clim.2008.03.460 · 2008 · External reference
CCR2-antagonist prophylaxis reduces pulmonary immune pathology and markedly improves survival during influenza infection
10.4049/jimmunol.1001002 · 2011 · External reference
10.4049/jimmunol.0902022
10.4049/jimmunol.0902022 · External reference
Productive replication of middle east respiratory syndrome coronavirus in monocyte-derived dendritic cells modulates innate immune response
10.1016/j.virol.2014.02.018 · 2014 · External reference
10.1172/jci.insight.91868
10.1172/jci.insight.91868 · External reference
Production of chemokines in the lungs of infants with severe respiratory syncytial virus bronchiolitis
10.1086/428855 · 2005 · External reference
10.1016/j.chom.2020.04.017
10.1016/j.chom.2020.04.017 · External reference
10.1093/infdis/jiaa363
10.1093/infdis/jiaa363 · External reference
10.1016/j.cell.2020.04.026
10.1016/j.cell.2020.04.026 · External reference
10.1038/nri722
10.1038/nri722 · External reference
10.1016/s2213-2600(20)30076-x
10.1016/s2213-2600(20)30076-x · External reference
10.1038/s41590-020-0779-1
10.1038/s41590-020-0779-1 · External reference
10.1080/22221751.2020.1747363
10.1080/22221751.2020.1747363 · External reference
10.1172/jci.insight.139834
10.1172/jci.insight.139834 · External reference
10.1172/jci.insight.138070
10.1172/jci.insight.138070 · External reference
10.1016/j.jaci.2020.04.027
10.1016/j.jaci.2020.04.027 · External reference
10.1001/jama.2020.5394
10.1001/jama.2020.5394 · External reference
10.1136/bmj.m1443
10.1136/bmj.m1443 · External reference
10.1016/j.meegid.2020.104512
10.1016/j.meegid.2020.104512 · External reference
CCR5 Δ32 minorallele is associated with susceptibility to SARS-CoV-2 infection and death: an epidemiological investigation
10.1016/j.cca.2020.07.012 · 2020 · External reference
10.1016/j.humimm.2017.10.001
10.1016/j.humimm.2017.10.001 · External reference
Genomewide association study of severe COVID-19 with respiratory failure
10.1056/nejmoa2020283 · 2020 · External reference
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia
10.1038/s41467-020-17292-4 · 2020 · External reference
10.1016/j.cell.2020.08.002
10.1016/j.cell.2020.08.002 · External reference
10.1101/2020.10.07.20208488
10.1101/2020.10.07.20208488 · External reference
10.1038/s41591-020-0819-2
10.1038/s41591-020-0819-2 · External reference
10.1093/cid/ciaa410
10.1093/cid/ciaa410 · External reference
Review on therapeutic targets for COVID-19: insights from cytokine storm
2020 · External reference
10.1128/jvi.02576-13
10.1128/jvi.02576-13 · External reference
Mapping the innate signaling cascade essential for cytokine storm during influenza virus infection
10.1073/pnas.1400593111 · 2014 · External reference
High-dose hydrocortisone reduces expression of the pro-inflammatory chemokines CXCL8 and CXCL10 in SARS coronavirus-infected intestinal cells
2005 · External reference
Rational for prolonged corticosteriod treatment in the acute respiratory distress syndrom caused by coronavirus disease 2019
2020 · External reference
Pharmacologic characteristics and adrenal suppression with newer inhaled corticosteroids: a comparison of ciclesonide and fluticasone propionate
10.1016/j.clinthera.2006.03.003 · 2006 · External reference
Fatal aspergillosis in a patient with SARS who was treated with corticosteroids
10.1056/nejm200307313490519 · 2003 · External reference
Cytokine storm in COVID-19: “When you come out of the storm, you won’t be the same person who walked in”
10.3389/fimmu.2020.02132 · 2020 · External reference
10.1038/s41392-020-0191-1
10.1038/s41392-020-0191-1 · External reference
Th17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib
10.1016/j.jmii.2020.03.005 · 2020 · External reference
10.4049/jimmunol.173.12.7602
10.4049/jimmunol.173.12.7602 · External reference
10.1016/j.bbrc.2003.10.075
10.1016/j.bbrc.2003.10.075 · External reference
10.1128/jvi.75.13.6095-6106.2001
10.1128/jvi.75.13.6095-6106.2001 · External reference
Acute lung injury: a clinical and molecular review
10.5858/arpa.2015-0519-ra · 2016 · External reference
Net balancing: a problem in inflammatory lung diseases
10.3389/fimmu.2013.00001 · 2013 · External reference
10.1016/j.humimm.2005.11.003
10.1016/j.humimm.2005.11.003 · External reference
10.1371/journal.pone.0032366
10.1371/journal.pone.0032366 · External reference
A novel neutrophil-activating factor produced by human mononuclear phagocytes
10.1084/jem.167.5.1547 · 1988 · External reference
Lung under attack by COVID-19-induced cytokine storm: pathogenic mechanisms and therapeutic implications
10.1177/1753466620933508 · 2020 · External reference
Critical role of endothelial CXCR2 in LPS-induced neutrophil migration into the lung
10.1172/jci27009 · 2006 · External reference
Re-analysis of single cell transcriptome reveals that the NR3C1-CXCL8- neutrophil axis determines the severity of COVID-19
2020 · External reference
Neutrophil extracellular traps in COVID-19
2020 · External reference
10.1074/jbc.273.17.10095
10.1074/jbc.273.17.10095 · External reference
10.1128/jvi.75.14.6450-6459.2001
10.1128/jvi.75.14.6450-6459.2001 · External reference
10.1124/jpet.106.119040
10.1124/jpet.106.119040 · External reference
10.1073/pnas.0402090101
10.1073/pnas.0402090101 · External reference
Humanized monoclonal antibody against the chemokine CXCL-8 (IL-8) effectively prevents acute lung injury
10.1016/j.intimp.2009.11.005 · 2010 · External reference
The role of CXCR2 in systemic neovascularization of the mouse lung
10.1152/japplphysiol.00037.2007 · 2007 · External reference
10.1158/0008-5472.can-05-3842
10.1158/0008-5472.can-05-3842 · External reference
10.3390/biom5031386
10.3390/biom5031386 · External reference
10.1016/j.cell.2008.02.043
10.1016/j.cell.2008.02.043 · External reference
Effects of the TLR2 agonists MALP-2 and Pam3cys in isolated mouse lungs
10.1371/journal.pone.0013889 · 2010 · External reference
10.4049/jimmunol.162.6.3549
10.4049/jimmunol.162.6.3549 · External reference
Regulation of pulmonary fibrosis by chemokine receptor CXCR3
10.1172/jci16861 · 2004 · External reference
10.1164/rccm.201203-0508oc
10.1164/rccm.201203-0508oc · External reference
10.1016/s1359-6101(97)00015-4
10.1016/s1359-6101(97)00015-4 · External reference
Monoclonal antibody against CXCL-10/IP-10 ameliorates influenza A (H1N1) virus induced acute lung injury
10.1038/cr.2013.25 · 2013 · External reference
10.1084/jem.187.12.2009
10.1084/jem.187.12.2009 · External reference
Characterization of beta-R1, a gene that is selectively induced by interferon beta (IFN-beta) compared with IFN-alpha
10.1074/jbc.271.37.22878 · 1996 · External reference
10.1172/jci141054
10.1172/jci141054 · External reference
10.1038/nm1091
10.1038/nm1091 · External reference
Lymphoid follicle cells in chronic obstructive pulmonary disease overexpress the chemokine receptor CXCR3
10.1164/rccm.200807-1089oc · 2009 · External reference
10.1038/s41590-018-0260-6
10.1038/s41590-018-0260-6 · External reference
10.1016/j.immuni.2014.09.007
10.1016/j.immuni.2014.09.007 · External reference
Unresolved reference
External reference
10.1016/j.cell.2020.05.006
10.1016/j.cell.2020.05.006 · External reference
10.1016/j.coviro.2011.10.026
10.1016/j.coviro.2011.10.026 · External reference
Should we stimulate or suppress immune responses in COVID-19?Cytokine and anti-cytokine interventions
10.1016/j.autrev.2020.102567 · 2020 · External reference
10.1038/s41591-020-0901-9
10.1038/s41591-020-0901-9 · External reference
Two distinct immunopathological profiles in autopsy lungs of COVID-19
10.1038/s41467-020-18854-2 · 2020 · External reference
10.1590/s1679-45082015rb3438
10.1590/s1679-45082015rb3438 · External reference
10.3390/ijms20112785
10.3390/ijms20112785 · External reference
Recombinant human MCP-1/JE induces chemotaxis, calcium flux, and the respiratory burst in human monocytes
10.1182/blood.v78.4.1112.1112 · 1991 · External reference
10.1073/pnas.0334864100
10.1073/pnas.0334864100 · External reference
10.4049/jimmunol.0904177
10.4049/jimmunol.0904177 · External reference
10.1038/sj.mn.7800193
10.1038/sj.mn.7800193 · External reference
10.4049/jimmunol.170.6.3273
10.4049/jimmunol.170.6.3273 · External reference
Differential monocyte chemoattractant protein-1 and chemokine receptor 2 expression by murine lung fibroblasts derived from Th1- and Th2-type pulmonary granuloma models
10.4049/jimmunol.163.4.2193 · 1999 · External reference
10.4049/jimmunol.180.4.2562
10.4049/jimmunol.180.4.2562 · External reference
10.1136/gutjnl-2015-310514
10.1136/gutjnl-2015-310514 · External reference
10.1371/journal.ppat.1002098
10.1371/journal.ppat.1002098 · External reference
10.1038/nm1303
10.1038/nm1303 · External reference
10.1101/2020.05.02.20084673
10.1101/2020.05.02.20084673 · External reference
RANTES mediates kidney ischemia reperfusion injury through a possible role of HIF-1α and LncRNA PRINS
10.1038/srep18424 · 2016 · External reference
Functional roles of CCL5/RANTES in liver disease
10.1016/j.livres.2020.01.002 · 2020 · External reference
10.1038/s41577-020-0331-4
10.1038/s41577-020-0331-4 · External reference
